UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Estrogen action, selective estrogen receptor modulators, and women's health
: progress and promise
2013, ISBN 9781848169579, xxxvi, 507
Book
Clinical cancer research, ISSN 1078-0432, 08/2018, Volume 24, Issue 15, pp. 3510 - 3518
Life Sciences & Biomedicine | Oncology | Science & Technology | Nausea - chemically induced | Receptor, ErbB-2 - genetics | Cinnamates - administration & dosage | Humans | Middle Aged | Selective Estrogen Receptor Modulators - adverse effects | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Drug-Related Side Effects and Adverse Reactions - pathology | Dose-Response Relationship, Drug | Aged, 80 and over | Adult | Female | Selective Estrogen Receptor Modulators - administration & dosage | Breast Neoplasms - drug therapy | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Indoles - adverse effects | Breast Neoplasms - pathology | Breast Neoplasms - blood | Cinnamates - adverse effects | Aged | Biomarkers, Tumor - genetics | Nausea - pathology | Drug-Related Side Effects and Adverse Reactions - classification | Tumor markers | Toxicity | Liver | Estrogens | Estrogen receptors | Diarrhea | Fatigue | Mass spectroscopy | Nausea | Breast cancer | Pharmacology | Patients | ErbB-2 protein | Anticancer properties | Safety engineering | Antitumor activity | Safety | Solid tumors | Mass spectrometry | Cancer | Tumors | Index Medicus
Journal Article
Clinical interventions in aging, ISSN 1176-9092, 09/2014, Volume 9, pp. 1437 - 1452
SERMs | Estrogen receptors | Selective estrogen receptor modulators | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Selective Estrogen Receptor Modulators - adverse effects | Female | Selective Estrogen Receptor Modulators - therapeutic use | Organ Specificity | Humans | Chronic diseases | Receptors | Pharmacology, Experimental | Health aspects | Risk factors | Estrogen | Disease prevention | Osteoporosis | Endometrial cancer | Metabolites | Womens health | Genes | Estrogens | Ligands | Breast cancer | Deoxyribonucleic acid--DNA | Index Medicus | selective estrogen receptor modulators | estrogen receptors | Selective Estrogen Receptor Modulators
Journal Article
Current clinical pharmacology, ISSN 1574-8847, 2013, Volume 8, Issue 2, pp. 135 - 155
Arzoxifene | Ospemifene | Selective estrogen receptor modulator | Bazedoxifene | Lasofoxifene | Raloxifene | Tamoxifen | Humans | Selective Estrogen Receptor Modulators - adverse effects | Osteoporosis, Postmenopausal - pathology | Clinical Trials as Topic | Breast Neoplasms - drug therapy | Drug Discovery | Osteoporosis, Postmenopausal - drug therapy | Animals | Selective Estrogen Receptor Modulators - therapeutic use | Breast Neoplasms - pathology | Drug Design | Female | Osteoporosis, Postmenopausal - prevention & control | Selective Estrogen Receptor Modulators - pharmacology
Journal Article
Expert opinion on drug safety, ISSN 1474-0338, 06/2015, Volume 14, Issue 6, pp. 921 - 934
bazedoxifene | fulvestrant | safety | toremifene | selective estrogen receptor modulator | raloxifene | lasofoxifene | ospemifene | tamoxifen | Ospemifene | Selective estrogen receptor modulator | Bazedoxifene | Lasofoxifene | Toremifene | Raloxifene | Safety | Tamoxifen | Fulvestrant | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Dyspareunia - drug therapy | Humans | Selective Estrogen Receptor Modulators - adverse effects | Estrogens - adverse effects | Breast Neoplasms - drug therapy | Osteoporosis, Postmenopausal - drug therapy | Estrogens - therapeutic use | Patient Selection | Estrogen Antagonists - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Estrogen Antagonists - adverse effects | Female | Drug Monitoring | Index Medicus
Journal Article
Drugs & aging, ISSN 1170-229X, 2007, Volume 24, Issue 5, pp. 361 - 379
Arzoxifene | Ospemifene | Bazedoxifene | Lasofoxifene | Toremifene | Raloxifene | Postmenopausal osteoporosis | Selective estrogen receptor modulators | Tamoxifen | Research and development | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Osteoporosis. Osteomalacia. Paget disease | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Diseases of the osteoarticular system | Receptors, Estrogen - metabolism | Bone Density | Humans | Osteoporosis, Postmenopausal - metabolism | Selective Estrogen Receptor Modulators - adverse effects | Selective Estrogen Receptor Modulators - chemistry | Selective Estrogen Receptor Modulators - administration & dosage | Clinical Trials as Topic | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Selective Estrogen Receptor Modulators - therapeutic use | Lipids - blood | Female | Aged | Molecular Structure | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 03/2003, Volume 46, Issue 7, pp. 1081 - 1111
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Hormones. Endocrine system | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Chemical agents | Carcinogenesis, carcinogens and anticarcinogens | Medical sciences | Antineoplastic agents | Tumors | Raloxifene Hydrochloride - adverse effects | Raloxifene Hydrochloride - pharmacology | Raloxifene Hydrochloride - therapeutic use | Estradiol Congeners - adverse effects | Humans | Endometrial Neoplasms - chemically induced | Antineoplastic Agents - therapeutic use | Structure-Activity Relationship | Estrogen Receptor Modulators - therapeutic use | Estrogen Receptor alpha | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents - adverse effects | Female | Steroids - pharmacology | Antineoplastic Agents - pharmacology | Steroids - therapeutic use | Osteoporosis, Postmenopausal - prevention & control | Drug Resistance | Steroids - chemistry | Estrogen Receptor Modulators - chemistry | Models, Molecular | Selective Estrogen Receptor Modulators - chemistry | Estrogen Receptor Modulators - pharmacology | Receptors, Estrogen - drug effects | Animals | Tamoxifen - therapeutic use | Tamoxifen - pharmacology | Tamoxifen - analogs & derivatives | Tamoxifen - adverse effects | Estrogen Receptor beta | Selective Estrogen Receptor Modulators - pharmacology | Index Medicus
Journal Article
Climacteric : the journal of the International Menopause Society, ISSN 1369-7137, 03/2019, Volume 22, Issue 2, pp. 140 - 147
tissue selective estrogen complex | estetrol | bazedoxifene | raloxifene | Selective estrogen receptor modulators | conjugated estrogens | tamoxifen | bazedoxifene/conjugated estrogens | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Hot Flashes - drug therapy | Raloxifene Hydrochloride - therapeutic use | Vagina - drug effects | Estrogens, Conjugated (USP) - administration & dosage | Humans | Middle Aged | Selective Estrogen Receptor Modulators - adverse effects | Breast Neoplasms - drug therapy | Indoles - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Breast Neoplasms - prevention & control | Female Urogenital Diseases - drug therapy | Indoles - adverse effects | Selective Estrogen Receptor Modulators - therapeutic use | Tamoxifen - therapeutic use | Atrophy - prevention & control | Postmenopause | Adult | Female | Aged | Estrogens, Conjugated (USP) - adverse effects | Vagina - pathology | Hormone replacement therapy | Breast cancer | Hyperplasia | Estrogens | Index Medicus
Journal Article